https://www.selleckchem.com/pr....oducts/itacnosertib.
antly increased point prevalence abstinence at 12 weeks. However, the difference was no longer significant at 24 weeks, and trial interpretation is limited by early termination and inconsistent findings for nicotine and nonnicotine e-cigarettes, suggesting further research is needed. ClinicalTrials.gov Identifier NCT02417467. ClinicalTrials.gov Identifier NCT02417467. The benefits of vitamin D, omega-3 fatty acids, and exercise in disease prevention remain unclear. To test whether vitamin D, omega-3s, and a strength-training exerci
כמו
תגובה
לַחֲלוֹק
